Exploring reasons for COVID-19 vaccine hesitancy among healthcare providers in Ethiopia.

Fisseha Shiferie, Oumer Sada, Theodros Fenta, Mirgissa Kaba, Atalay Mulu Fentie
Author Information
  1. Fisseha Shiferie: Department of Epidemiology and Biostatistics, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
  2. Oumer Sada: Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, College of Health Sciences, School of Pharmacy, Addis Ababa, Ethiopia.
  3. Theodros Fenta: Department of Medicine Registration and Licensing Directorate, Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia.
  4. Mirgissa Kaba: Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
  5. Atalay Mulu Fentie: Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, College of Health Sciences, School of Pharmacy, Addis Ababa, Ethiopia.

Abstract

INTRODUCTION: the World Health Organization has identified vaccine hesitancy as one of the top ten threats to global health. The purpose of this study was to explore factors contributing to COVID-19 vaccine hesitancy among healthcare providers, their perspectives regarding vaccine uptake by the public and their recommendations to improve vaccine uptake in Ethiopia.
METHODS: a phenomenological qualitative study was conducted among purposively selected healthcare providers working in the Ministry of Health (MoH), regulatory authority, public and private hospitals and health centres who hesitated to take the COVID-19 vaccine in Addis Ababa, Ethiopia in June 2021. A total of twenty in-depth interviews were conducted using a semi-structured open-ended interview guide. Participants included nurses, physicians, pharmacists, health officers, Medical Laboratory technologists and midwives. A qualitative content analysis approach was chosen to analyse the data.
RESULTS: all the participants agreed (n=20) that lack of consistent information and inadequate evidence about COVID-19 vaccine safety, efficacy and quality were the main reasons for COVID-19 vaccine hesitancy. History of perceived and confirmed COVID-19 infection history, misinformation, religious views, unknown short and long-term effects of the vaccine and undefined length of time of vaccine´s protection were also other reasons mentioned by the participants.
CONCLUSION: healthcare providers were hesitant toward COVID-19 vaccine mainly due to lack of clear evidence regarding the vaccine´s short and long-term safety, efficacy and quality profiles. Hence, the long-term safety and efficacy of the vaccine should be extensively studied and evidence dissemination and communication should be clear and transparent.

Keywords

References

  1. JAMA Health Forum. 2021 Mar 1;2(3):e210434 [PMID: 36218456]
  2. BMC Public Health. 2021 Apr 8;21(1):685 [PMID: 33832478]
  3. Glob Health Res Policy. 2021 Jul 12;6(1):23 [PMID: 34253254]
  4. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  5. Am J Health Syst Pharm. 2013 Feb 1;70(3):195-283 [PMID: 23327981]
  6. Vaccines (Basel). 2019 Oct 18;7(4): [PMID: 31635270]
  7. Clinicoecon Outcomes Res. 2021 Apr 22;13:279-287 [PMID: 33935506]
  8. NPJ Vaccines. 2021 Apr 14;6(1):54 [PMID: 33854072]
  9. BMJ Open. 2012 Aug 17;2(4): [PMID: 22904334]
  10. J Autoimmun. 2020 May;109:102442 [PMID: 32253068]
  11. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  12. Curr Opin Pediatr. 2020 Feb;32(1):151-159 [PMID: 31790027]
  13. Vaccine. 2015 Jan 9;33(3):459-64 [PMID: 25499651]
  14. N Engl J Med. 2020 Oct 29;383(18):1701-1703 [PMID: 32846056]
  15. Nat Hum Behav. 2021 Jul;5(7):947-953 [PMID: 33972767]
  16. N Engl J Med. 2009 May 7;360(19):1981-8 [PMID: 19420367]
  17. J Multidiscip Healthc. 2021 May 28;14:1233-1243 [PMID: 34093019]
  18. J Med Virol. 2021 Jul;93(7):4280-4291 [PMID: 33644891]
  19. Arch Dis Child. 2021 Feb;106(2):113-114 [PMID: 32912868]

MeSH Term

COVID-19
COVID-19 Vaccines
Ethiopia
Health Personnel
Humans
SARS-CoV-2
Vaccination Hesitancy

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccineCOVID-19hesitancyhealthcareprovidersEthiopiahealthamongevidencesafetyefficacyreasonslong-termHealthstudyregardinguptakepublicqualitativeconductedparticipantslackqualityshortvaccine´sclearINTRODUCTION:WorldOrganizationidentifiedonetoptenthreatsglobalpurposeexplorefactorscontributingperspectivesrecommendationsimproveMETHODS:phenomenologicalpurposivelyselectedworkingMinistryMoHregulatoryauthorityprivatehospitalscentreshesitatedtakeAddisAbabaJune2021totaltwentyin-depthinterviewsusingsemi-structuredopen-endedinterviewguideParticipantsincludednursesphysicianspharmacistsofficersMedicalLaboratorytechnologistsmidwivescontentanalysisapproachchosenanalysedataRESULTS:agreedn=20consistentinformationinadequatemainHistoryperceivedconfirmedinfectionhistorymisinformationreligiousviewsunknowneffectsundefinedlengthtimeprotectionalsomentionedCONCLUSION:hesitanttowardmainlydueprofilesHenceextensivelystudieddisseminationcommunicationtransparentExploring

Similar Articles

Cited By